Glucose Oxidase‐Immobilized Dually‐Crosslinked Nanogels for Rapid‐Responsive Insulin Delivery
Advanced Healthcare Materials · 2024
DOI: 10.1002/adhm.202402556 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Yuhong Ma und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Engineering, School of Engineering, China Pharmaceutical University, Nanjing, 211198, P. R. China. Hauptthemen laut MEDLINE: Glucose Oxidase, Insulin, Enzymes, Immobilized, Nanogels. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Demonstration Project of Modern Agricultural Machinery Equipment &Technology in Jiangsu Province, Outstanding Young Backbone Teacher and Excellent Teaching Team of the "Blue Project" in Jiangsu Province.
Abstract (Originalsprache)
Despite the potential benefits of close‐looped insulin delivery systems in regulating glycemic homeostasis and effectively alleviating diabetes, they still encounter challenges such as limited effectiveness in preventing low glycemic episodes due to sluggish glucose response, and issues with the instability of enzymes and carriers. In this study, dually‐crosslinked and glucose oxidase (GOx)‐immobilized insulin nanogels (DC‐NGs@Ins) are developed for rapid‐responsive and sustained hypoglycemic therapy. The DC‐NGs@Ins with the phenylborate ester linker enabled the insulin release in a close‐looped fashion, and moreover, immobilized GOx‐generated hydrogen peroxide (H 2 O 2 ) by consuming the glucose, which can further bind to phenylborate ester for enhancing glucose response and accelerating the insulin release. The dually‐crosslinked structure (phenylboronic ester and UV‐crosslinking) effectively minimized the initial burst release of insulin, thus preventing the potential risk of hypoglycemia. More interestingly, GOx immobilized in the nanogels mitigated GOx leakage and enhanced its multiple utilization compared to free GOx. In vivo study demonstrated that DC‐NGs@Ins effectively maintained glycemic levels (BGLs) below 200 mg dL −1 for at least 8 h compared to singly‐crosslinked nanogels (SC‐NGs@Ins). Therefore, this intelligent insulin delivery system shows potential applications in diabetes treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Engineering, School of Engineering, China Pharmaceutical University, Nanjing, 211198, P. R. China.
- School of Energy and Mechanical Engineering, Nanjing Normal University, Nanjing, 210023, P. R. China.
ORCID-Profile: Hongliang Qian, Wei Chen
Förderung
- National Natural Science Foundation of China
- Demonstration Project of Modern Agricultural Machinery Equipment &Technology in Jiangsu Province
- Outstanding Young Backbone Teacher and Excellent Teaching Team of the "Blue Project" in Jiangsu Province
Zitieren
APA
Ma, Y., Yang, J., Ma, Y., Yang, R., Han, F., He, M., Liu, W., Qian, H., Chen, W., & Huang, D. (2024). Glucose Oxidase‐Immobilized Dually‐Crosslinked Nanogels for Rapid‐Responsive Insulin Delivery. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202402556
Vancouver
Ma Y, Yang J, Ma Y, Yang R, Han F, He M, et al. Glucose Oxidase‐Immobilized Dually‐Crosslinked Nanogels for Rapid‐Responsive Insulin Delivery. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202402556
BibTeX
@article{Ma2024,
author = {Ma, Yuhong and Yang, Jingru and Ma, Yukun and Yang, Rui and Han, Fuwei and He, Mujiao and Liu, Wei and Qian, Hongliang and Chen, Wei and Huang, Dechun},
title = {Glucose Oxidase‐Immobilized Dually‐Crosslinked Nanogels for Rapid‐Responsive Insulin Delivery},
journal = {Advanced Healthcare Materials},
year = {2024},
doi = {10.1002/adhm.202402556}
}
EUVIMED